Bouguenais, France

Maxim Egorov

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Nantes, FR (2013)
  • Bouguenais, FR (2015 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Maxim Egorov: Pioneer in Oncology Innovation

Introduction

Maxim Egorov, an esteemed inventor based in Bouguenais, France, has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of four patents to his name, Egorov demonstrates a commitment to enhancing medical therapies through innovative chemical compounds.

Latest Patents

Maxim Egorov's latest patents include advancements that address critical health challenges. One notable patent is for "Hydrosoluble Hydroxybisphosphonic Derivatives of Doxorubicin," which involves hydrosoluble derivatives and their pharmaceutically acceptable salts. This invention aims to provide new treatment options for bone tumors through effective pharmaceutical compositions and synthesis methods.

Another remarkable invention is for "N-Substituted 3,4-bis(catechol) Pyrrole Compounds," which outlines the preparation and application of these compounds in cancer treatment. This patent encompasses various chemical formulations and their potential benefits in therapeutic settings, further showcasing Egorov's innovative approach to improving cancer therapies.

Career Highlights

Throughout his esteemed career, Maxim Egorov has collaborated with relevant institutions, including Atlanthera and the Centre National De La Recherche Scientifique. His work has not only contributed to scientific knowledge but has also aimed at improving patient outcomes through innovative drug development.

Collaborations

Egorov has worked alongside notable colleagues such as Jean-Yves Goujon and Ronan Le Bot, enhancing his research through collaborative efforts. These partnerships have notably enriched the quality and impact of his inventions, reinforcing the importance of teamwork in scientific advancements.

Conclusion

Maxim Egorov's contributions to the field of oncology through his innovative patents reveal the potential for new treatments and therapies in combating cancer. His relentless pursuit of scientific discovery reflects a deep commitment to improving health outcomes through innovation. As he continues to advance his research, the medical community eagerly anticipates the potential applications of his findings in clinical settings.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…